Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancer With Serum VEGF as Primary Endpoint: The NEOZOL Study
- Resource Type
- Article
- Source
- In
Clinical Breast Cancer December 2018 18(6):e1311-e1321 - Subject
- Language
- ISSN
- 1526-8209